drugset / Trial / NCT03414255

Micronized dHACM Injectable for the Treatment of Achille Tendonitis

NCT03414255 ↗

Phase 3 Completed 146 enrolled MiMedx Group, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis

Timeline

Start
2018-01-09
Primary completion
2021-03-30
Completion
2021-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydrated human amnion/chorion membrane Unknown 40 mg —

Indications